Onyx Biotec Limited (NSE: ONYX) is a Chandigarh-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹65 Cr, it ranks #3,593 by market cap among the 6,197 Indian listed companies on FinBizNet, and #20 of 26 in Pharmaceutical Contract Manufacturing Services. The share price was ₹35.70 as of 16 Nov 2026.
| Current Price | ₹35.70 |
|---|---|
| Market Cap | ₹65 Cr |
| NSE Symbol | ONYX |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -0.38% |
| Return on Assets | 0.24% |
| Beta (1Y) | 0.52 |
| Headquarters | Chandigarh |
| Website | www.onyxbiotec.com |
Promoters held 65.10% of Onyx Biotec Limited's shares as of Mar 2026, unchanged from Mar 2025.
Onyx Biotec Limited develops, manufactures, and distributes generic and proprietary pharmaceutical products in India and internationally. The company offers water for injections (WFI), dry powder injections, and dry powder syrup. It also exports its products. Onyx Biotec Limited was incorporated in 2005 and is based in Chandigarh, India.
1. Manufacturing of Pharmaceutical Products-This segment engages in manufacturing pharmaceutical products, such as sterile water ampoules, dry injections, and dry syrups. 2. NA-NA 3. NA-NA 4. NA-NA
1. Manufacturing of Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,79,494 Cr | 73.6 | 16.98% | ₹4,979 Cr | +30.4% |
| Aether Industries Limited | ₹21,710 Cr | 101.8 | 9.81% | ₹347 Cr | +127.8% |
| Alivus Life Sciences Ltd | ₹17,862 Cr | 31.5 | 18.36% | ₹682 Cr | +64.0% |
| Aarti Pharmalabs Ltd | ₹8,374 Cr | 52.5 | 8.49% | ₹610 Cr | +15.4% |
| Solara Active Pharma Sciences Limited | ₹3,225 Cr | n/m | -0.63% | ₹417 Cr | +22.1% |
| Sai Parenteral's Limited | ₹2,235 Cr | 115.8 | 2.88% | ₹195 Cr | — |
| KRM Ayurveda Limited | ₹521 Cr | 25.9 | 17.54% | ₹32 Cr | — |
| Trident Lifeline Limited | ₹511 Cr | 26 | — | — | +37.6% |
| Onyx Biotec Limited | ₹65 Cr | n/m | -0.38% | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Onyx Biotec Limited is trading at ₹35.70, with a market capitalisation of ₹65 Cr.
Onyx Biotec Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Onyx Biotec Limited has a return on equity of -0.38%.
Onyx Biotec Limited is listed on the NSE under the symbol ONYX.
Promoters held 65.10% of Onyx Biotec Limited's shares as of Mar 2026, unchanged from Mar 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.